Huapont Life Sciences Co Ltd (002004) — Financial Flexibility Index
Huapont Life Sciences Co Ltd (002004) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥795.22 Million (operating CF CN¥635.17 Million minus capex CN¥160.05 Million) represents 0% of total liabilities (CN¥13.15 Billion). Check Huapont Life Sciences Co Ltd (002004) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Huapont Life Sciences Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Huapont Life Sciences Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Huapont Life Sciences Co Ltd.
Annual Financial Flexibility Index for Huapont Life Sciences Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for Huapont Life Sciences Co Ltd. Explore 002004 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥2.73 Billion | CN¥2.10 Billion | CN¥12.05 Billion | ▲ +22.9% |
| 2024 | 0.18x | CN¥2.58 Billion | CN¥1.63 Billion | CN¥13.98 Billion | ▼ -9.1% |
| 2023 | 0.20x | CN¥2.87 Billion | CN¥1.59 Billion | CN¥14.14 Billion | ▼ -22.6% |
| 2022 | 0.26x | CN¥3.54 Billion | CN¥2.41 Billion | CN¥13.47 Billion | ▲ +47.9% |
| 2021 | 0.18x | CN¥2.53 Billion | CN¥1.27 Billion | CN¥14.22 Billion | ▼ -30.6% |
| 2020 | 0.26x | CN¥3.60 Billion | CN¥2.37 Billion | CN¥14.09 Billion | ▼ -2.6% |
| 2019 | 0.26x | CN¥3.52 Billion | CN¥2.08 Billion | CN¥13.39 Billion | ▲ +20.4% |
| 2018 | 0.22x | CN¥3.01 Billion | CN¥1.91 Billion | CN¥13.80 Billion | ▲ +120.1% |
| 2017 | 0.10x | CN¥1.56 Billion | CN¥591.40 Million | CN¥15.79 Billion | ▲ +15.1% |
| 2016 | 0.09x | CN¥1.16 Billion | CN¥511.90 Million | CN¥13.52 Billion | ▼ -31.9% |
| 2015 | 0.13x | CN¥1.17 Billion | CN¥342.45 Million | CN¥9.30 Billion | ▼ -5.0% |
| 2014 | 0.13x | CN¥1.04 Billion | CN¥455.96 Million | CN¥7.84 Billion | ▼ -33.8% |
| 2013 | 0.20x | CN¥729.31 Million | CN¥349.51 Million | CN¥3.64 Billion | ▲ +3.8% |
| 2012 | 0.19x | CN¥572.96 Million | CN¥257.75 Million | CN¥2.97 Billion | ▲ +34.1% |
| 2011 | 0.14x | CN¥230.99 Million | CN¥135.23 Million | CN¥1.60 Billion | ▼ -66.0% |
| 2010 | 0.42x | CN¥136.71 Million | CN¥79.84 Million | CN¥322.58 Million | ▼ -47.1% |
| 2009 | 0.80x | CN¥196.99 Million | CN¥123.53 Million | CN¥245.68 Million | ▲ +26.4% |
| 2008 | 0.63x | CN¥206.25 Million | CN¥113.76 Million | CN¥325.26 Million | ▲ +11.6% |
| 2007 | 0.57x | CN¥203.23 Million | CN¥79.21 Million | CN¥357.78 Million | ▲ +20.8% |
| 2006 | 0.47x | CN¥113.87 Million | CN¥66.10 Million | CN¥242.18 Million | ▼ -80.2% |
| 2005 | 2.37x | CN¥88.12 Million | CN¥43.69 Million | CN¥37.17 Million | ▲ +93.2% |
| 2004 | 1.23x | CN¥97.43 Million | CN¥70.60 Million | CN¥79.39 Million | ▲ +12.2% |
| 2003 | 1.09x | CN¥87.50 Million | CN¥56.68 Million | CN¥79.99 Million | ▲ +28.1% |
| 2002 | 0.85x | CN¥89.59 Million | CN¥36.88 Million | CN¥104.91 Million | — |